A Seattle Times investigation has found "scores" of cases where doctors have sold investors access to information about ongoing clinical trials in violation of SEC rules. Researchers at top institutions "from UCLA to the University of Pennsylvania" are implicated. This morning, Sen. Chuck Grassley (R -Iowa) called for an SEC inquiry. Investigation | Grassley's response